Integra Lifesciences Holdings Corp (NASDAQ:IART) is set to release its Q2 2025 earnings on Jul 31, 2025. The consensus ...

Medical device company Integra LifeSciences (NASDAQ:IART) reported Q2 CY2025 results beating Wall Street’s revenue ...

For the current quarter ending in September, Integra expects its per-share earnings to range from 40 cents to 45 cents. The company said it expects revenue in the range of $410 million to $420 million ...

Integra LifeSciences (Nasdaq: IART) shares are on the rise today on second-quarter results that beat the consensus forecast.

Chairperson and overseer of Bora Agro Nigeria Limited, an arm of the Institute of Agricultural Research and Training (IAR&T), ...

Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the second ...

Integra LifeSciences Holdings Corporation (IART) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings.

M, consensus $418.83M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial ...

Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial ...

Integra LifeSciences Holdings Corp. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View IART financial statements in full.

Integra LifeSciences Holdings Corp. annual cash flow and in depth look at IART operating, investing, and financing activities.